Amro M Abdelrahman
7PUBLICATIONS
48CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 18, 2026
KLF5 controls subtype-independent highly interactive enhancers in pancreatic cancer to regulate cell survival.Thomas L Ekstrom, Zhangshuai Dai, Julia Thiel
|Mar 18, 2026
Epigenetic context defines the transcriptional activity of canonical and noncanonical NF-κB signaling in pancreatic cancer.Joana E Aggrey-Fynn, Joshua Busch, Dominik Saul
|Feb 06, 2026
Multiomics-driven discovery of predictive biomarkers and strategies to overcome resistance to SFK-YAP inhibition in cholangiocarcinoma.Hendrien Kuipers, Danielle M Carlson, Erik Jessen
|Jul 09, 2025
Therapeutic targeting of FOSL1 and RELA-dependent transcriptional mechanisms to suppress pancreatic cancer metastasis.Joana E Aggrey-Fynn, Meghana Manjunath, Ashish Rajput
|Mar 13, 2024
Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor Upamostat and the Sphingosine Kinase 2 Inhibitor Opaganib on Cholangiocarcinoma Patient-Derived Xenografts.Faizal Z Asumda, Nellie A Campbell, Mohamed A Hassan
|Jun 06, 2023
Identification of a ΔNp63-Dependent Basal-Like A Subtype-Specific Transcribed Enhancer Program (B-STEP) in Aggressive Pancreatic Ductal Adenocarcinoma.Xin Wang, Ana P Kutschat, Joana Aggrey-Fynn
Pageof 2
Frequent Collaborators
3 joint publications
Julia Thiel
3 joint publications
Meng Dong
3 joint publications
Steven A Johnsen
3 joint publications
Mark J Truty
2 joint publications
Nadine Schacherer
2 joint publications
Jennifer A Yonkus
2 joint publications
Nellie A Campbell
2 joint publications
Lewis R Roberts
2 joint publications
Gregory J Gores
1 joint publications
Wanwan Ge
